S. Modi
发表论文 290 篇 · 总被引 16489 次 · h-index 55
代表论文
- Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial (2025 · Nature Medicine · 被引 39)
- Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and Binding (2025 · Cancer Discovery · 被引 31)
- Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer: a plain language summary of the DESTINY-Breast04 study (2025 · Future Oncology · 被引 16)
- Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician’s choice of chemotherapy in patients with HER2-low mBC (2025 · The Oncologist · 被引 13)
- Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan (2025 · JCO Precision Oncology · 被引 11)
- Abstract CT204: Phase 1a/b study of runimotamab, a HER2 x CD3 T cell-engaging bispecific antibody, administered as a single agent and in combination with trastuzumab in patients with HER2-expressing breast cancer (BC) (2025 · Cancer Research · 被引 6)